Methotrexate and corticosteroid therapy for pediatric localized scleroderma

Journal of Pediatrics

Volumn 136, Issue 1, 2000, Pages 91-95

  Uziel, Yosef ^b   Feldman, Brian M ^b   Krafchik, Bernice R ^b   Yeung, Rae S M ^b   Laxer, Ronald M ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; METHOTREXATE; METHYLPREDNISOLONE;

ARTICLE; CHILD; CLINICAL ARTICLE; DISEASE DURATION; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; LEUKOPENIA; MALE; PRIORITY JOURNAL; SCLERODERMA; SYSTEMIC SCLEROSIS;

EID: 0033927514     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(00)90056-8     Document Type: Article

References (33)

1. Uziel Y, Krafchik BR, Silverman ED, Thorner PS, Laxer RM. Localized scleroderma in childhood: a report of 30 cases. Semin Arthritis Rheum 1994; 23:328-40.
2. Liu P, Uziel Y, Chuang S, Silverman E, Krafchik B, Laxer R. Localized scleroderma: imaging features. Pediatr Radiol 1994;24:207-9.
3. Uziel Y, Krafchik BR, Silverman ED, Liu P, Laxer RM. Orthopedic manifestations of localized scleroderma in children. J Orthoped Rheum 1994;7:224-7.
4. Lehman TJA. The Parry Romberg syndrome of progressive facial hemiatrophy and linear scleroderma en coup de sabre: mistaken diagnosis or overlapping conditions? J Rheumatol 1992;19:844-5.
5. Joly P, Bamberger N, Crickx B, Belaich S. Treatment of severe forms of localized scleroderma with oral corticosteroids: follow-up study on 17 patients. Arch Dermatol 1994;130:663-4.
6. Falanga V, Medsger TA Jr. D-penicillamine in the treatment of localized scleroderma. Arch Dermatol 1990;126: 609-12.
7. Hulshof MM, Pavel S, Breedveld FC, Dijkmans BA, Vermeer BJ. Oral calcitriol as a new therapeutic modality for generalized morphea. Arch Dermatol 1994;130:1290-3.
8. Humbert P, Aubin F, Dupond JL, Delaporte E. Oral calcitriol as a new therapeutic agent in localized and systemic scleroderma. Arch Dermatol 1995;131: 850-1.
9. Elst EF, van Suijlekom LWA, Smith LW, Oranje AP. Treatment of linear scleroderma with oral 1-25 dihydroxy-vitamin D3 (calcitriol) in seven children. Pediatr Dermatol 1999;16:53-8.
10. Cunningham BB, Landells IDR, Langman C, Sailer DE, Paller AS. Topical calcipotriene for morphea/linear scleroderma. J Am Acad Dermatol 1998;39:211-5.
11. Kerscher M, Dirschka T, Volkenandt M. Treatment of localised scleroderma by UVA1 phototherapy. Lancet 1995; 346:1166.
12. Stege H, Berneburg M, Humke S, Klammer M, Grewe M, Grether-Beck S, et al. High-dose UVA1 radiation therapy for localized scleroderma. J Am Acad Dermatol 1997;36:938-44.
13. Gruss C, Stucker M, Kobyletzki G, Schreiber D, Altmeyer P, Kerscher M. Low dose UVA1 phototherapy in disabling pansclerotic morphoea of childhood. Br J Dermatol 1997;136:293-4.
14. Peter RU, Ruzicka T, Eckert F. Low-dose cyclosporine A in the treatment of disabling morphea. Arch Dermatol 1991;127:1420-1.
15. Hunzelmann N, Anders S, Fierlbeck G, Hein R, Hermann K, Albrect M. Double blind, placebo-controlled study of intralesional interferon gamma for the treatment of localized scleroderma. J Am Acad Dermatol 1997;36:433-5.
16. Lehman TJA. Systemic and localized scleroderma in children. Curr Opin Rheumatol 1996;8:576-9.
17. Foeldvari I. Progressive linear scleroderma and morphea in a child. J Pediatr 1998;133:308.
18. Seyger MMB, van der Hoogen FHJ, de Boo T, de Jong EMGJ. Low-dose methotrexate in the treatment of wide-spread morphea. J Am Acad Dermatol 1998;39:220-5.
19. Sato S, Fujimoto M, Kikuchi K, Ihn H, Tamaki K, Takehara K. Soluble CD4 and CD8 in serum from patients with localized scleroderma. Arch Dermatol Res 1996;288:358-62.
20. Sato S, Fujimoto M, Kikuchi K, Ihn H, Tamaki K, Takehara K. Elevated soluble CD23 levels in the sera from patients with localized scleroderma. Arch Dermatol Res 1996;288:74-8.
21. Ihn H, Sato S, Fujimoto M, Kikuchi K, Takehara K. Demonstration of interleukin-2, interleukin-4 and interleukin-6 in sera from patients with localized scleroderma. Arch Dermatol Res 1995;287:193-7.
22. Ihn H, Sato S, Fujimoto M, Kikuchi K, Takehara K. Demonstration of interleukin-8 in serum samples of patients with localized scleroderma. Arch Dermatol 1994;130:1327-8.
23. Uziel Y, Krafchik BR, Feldman B, Silverman ED, Rubin LA, Laxer RM. Serum soluble interleukin-2-receptor levels: a marker of disease activity in localized scleroderma. Arthritis Rheum 1994;37:898-901.
24. Ihn H, Sato S, Fujimoto M, Kikuchi K, Takehara K. Clinical significance of serum levels of soluble interleukin-2 receptor in patients with localized scleroderma. Br J Dermatol 1996;134: 843-7.
25. Rose CD, Fawcett PT, Gibney K, Doughty RA, Singsen BH. Serial measurements of soluble interleukin 2 receptor levels (sIL2-R) in children with rheumatoid arthritis treated with oral methotrexate. Ann Rheum Dis 1994; 53:471-4.
26. Barrera P, Haagsma CJ, Boerbooms AM, van Kiel PL, Borm GF, van de Putte LB, et al. Effect of methotrexate alone or in combination with sulphasalazine on the production and circulating concentrations of cytokines and their antagonists: longitudinal evalua tion in patients with rheumatoid arthritis. Br J Rheumatol 1995;34:747-55.
27. Seitz M, Loetscher P, Dewald B, Towbin H, Rordorf C, Gallati H, et al. Methotrexate action in rheumatoid arthritis: stimulation of cytokine inhibitor and inhibition of chemokine production by peripheral blood mononuclear cells. Br J Rheumatol 1995; 34:602-9.
28. van den Hoogen FH, Boerbooms AM, Swaak AJ, Rasker JJ, van Lier HJ, van de Putte LB. Comparison of methotrexate with placebo in the treatment of systemic sclerosis: a 24 week randomized double-blind trial, followed by a 24 week observational trial. Br J Rheumatol 1996;35:364-72.
29. Clements PJ, Lachenbruch PA, Seibold JR, Zee B, Steen VD, Brennan P, et al. Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J Rheumatol 1993;20:1892-6.
30. Birdi N, Shore A, Rush P, Laxer RM, Silverman ED, Krafchik B. Childhood linear scleroderma: a possible role of thermography for evaluation. J Rheumatol 1992;19:968-73.
31. Ishikawa T, Tamura T. Measurement of skin elastic properties with a new suction device (II): systemic sclerosis. J Dermatol 1996;23:165-8.
32. Scheja A, Akesson A. Comparison of high frequency (20MHz) ultrasound and palpation for the assessment of skin involvement in systemic sclerosis (scleroderma). Clin Exp Rheumatol 1997;15:283-8.
33. Nives Parodi M, Castagneto C, Filaci G, Murdaca G, Puppo F, Indiveri F, et al. Plicometer skin test: a new technique for the evaluation of cutaneous involvement in systemic sclerosis. Br J Rheumatol 1997;32:244-50.